Kazemnejad Somaieh, Khanmohammadi Manijeh, Mobini Sahba, Taghizadeh-Jahed Masoud, Khanjani Sayeh, Arasteh Shaghayegh, Golshahi Hannaneh, Torkaman Giti, Ravanbod Roya, Heidari-Vala Hamed, Moshiri Ali, Tahmasebi Mohammad-Naghi, Akhondi Mohammad-Mehdi
Reproductive Biotechnology Research Center, Avicenna Research Institute, Academic Center for Education, Culture and Research (ACECR), P.O. Box: 19615-1177, Tehran, Iran.
Department of Pathology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
Cell Tissue Res. 2016 Jun;364(3):559-572. doi: 10.1007/s00441-015-2355-9. Epub 2016 Jan 29.
The reconstruction capability of osteochondral (OCD) defects using silk-based scaffolds has been demonstrated in a few studies. However, improvement in the mechanical properties of natural scaffolds is still challengeable. Here, we investigate the in vivo repair capacity of OCD defects using a novel Bombyx mori silk-based composite scaffold with great mechanical properties and porosity during 36 weeks. After evaluation of the in vivo biocompatibility and degradation rate of these scaffolds, we examined the effectiveness of these fabricated scaffolds accompanied with/without autologous chondrocytes in the repair of OCD lesions of rabbit knees after 12 and 36 weeks. Moreover, the efficiency of these scaffolds was compared with fibrin glue (FG) as a natural carrier of chondrocytes using parallel clinical, histopathological and mechanical examinations. The data on subcutaneous implantation in mice showed that the designed scaffolds have a suitable in vivo degradation rate and regenerative capacity. The repair ability of chondrocyte-seeded scaffolds was typically higher than the scaffolds alone. After 36 weeks of implantation, most parts of the defects reconstructed by chondrocytes-seeded silk scaffolds (SFC) were hyaline-like cartilage. However, spontaneous healing and filling with a scaffold alone did not eventuate in typical repair. We could not find significant differences between quantitative histopathological and mechanical data of SFC and FGC. The fabricated constructs consisting of regenerated silk fiber scaffolds and chondrocytes are safe and suitable for in vivo repair of OCD defects and promising for future clinical trial studies.
一些研究已证明使用丝基支架修复骨软骨(OCD)缺损的能力。然而,提高天然支架的力学性能仍然具有挑战性。在此,我们研究了一种新型的具有良好力学性能和孔隙率的家蚕丝基复合支架在36周内对OCD缺损的体内修复能力。在评估这些支架的体内生物相容性和降解率后,我们检查了这些制备的支架在添加/不添加自体软骨细胞的情况下对兔膝关节OCD损伤修复12周和36周后的有效性。此外,通过平行的临床、组织病理学和力学检查,将这些支架的效果与作为软骨细胞天然载体的纤维蛋白胶(FG)进行了比较。小鼠皮下植入的数据表明,设计的支架具有合适的体内降解率和再生能力。接种软骨细胞的支架的修复能力通常高于单独的支架。植入36周后,接种软骨细胞的丝支架(SFC)重建的缺损大部分为透明软骨样。然而,单独使用支架的自发愈合和填充并没有导致典型的修复。我们在SFC和FGC的定量组织病理学和力学数据之间未发现显著差异。由再生丝纤维支架和软骨细胞组成的制备物对于OCD缺损的体内修复是安全且合适的,并且有望用于未来的临床试验研究。